Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep1097 | Hot topics (including COVID-19) | ECE2020

Central hypothyroidism: Are patients undertreated?

Marlier Joke , Bruno Lapauw , T’sjoen Guy , Defreyne Justine

Introduction: Thyroid hormone (TH) replacement therapy in patients with central hypothyroidism (CHT) cannot be reliably guided by TSH levels. Guidelines suggest substitution doses between 1.2–1.6 µg/kg body weight, aiming for free thyroxine levels (fT4) prior to intake in the upper part of normal. However, variability in TH metabolism, concomitant treatments and inaccurate interpretation of TSH levels still puts patients with CHT at risk for inappropriate substituti...

ea0063oc12.5 | Endocrine Connections 2 | ECE2019

Sexual desire in transgender persons in relation with gender affirming hormone treatment: Results from ENIGI, a large multicenter prospective cohort study in transgender people

Defreyne Justine , Kreukels Baudewijntje , T'Sjoen Guyt , Heijer Martin Den , Heylens Gunter , Elaut Els

Background: The effect of testosterone on sexual arousal has been described in testosterone withdrawal and re-adminstration studies in birth-assigned males. In birth-assigned females, the relationship between sex steroids and sexual arousal is complex. Several steps in the transitioning process may affect sexual desire: hormone therapy (HT) and gender affirming surgery. HT in transgender men (TM) generally leads to increased sexual desire, masturbation frequency, sexual fantas...

ea0063oc14.2 | Sex Hormones | ECE2019

The effect of testosterone therapy on serum oestradiol levels in transgender men

Defreyne Justine , Aers Xavier-Philippe , Daphne Fisher Alessandra , Schreiner Thomas , Den Heijer Martin , T'Sjoen Guy

Background: Testosterone therapy in transgender men (TM) is aimed at achieving serum testosterone levels in the male reference range. It remains unknown if serum oestradiol levels in TM should be evaluated and/or adjusted. Although reported serum oestradiol levels in TM are variable in the current literature, these values may be affected through two possible mechanisms: serum oestradiol levels may increase through aromatization of exogenous testosterone, while the effects of e...

ea0049ep1032 | Pituitary - Clinical | ECE2017

Does cyproterone acetate therapy contribute to the observed elevation in serum prolactin levels in trans women?

Defreyne Justine , Nota Nienke , Perreira Cecilia , Thomas Schreiner , Daphne Fisher Alessandra , Guy T'Sjoen

Objective: Hormonal treatment in trans women (MtF transgender persons) in Europe usually consists of estrogens and anti-androgens, e.g. cyproterone acetate (CPA). After initiation of cross-sex hormone therapy, an elevation in serum prolactin levels is frequently observed in trans women, which was previously attributed to estrogen agents. This analysis evaluates whether CPA contributes to the elevation of prolactin in trans women receiving cross-sex hormones.<p class="abste...

ea0056p366 | Diabetes (to include epidemiology, pathophysiology) | ECE2018

Does gender-affirming hormone therapy alter insulin resistance in transgender persons?

Abosi-Appeadu Kessewa , Maertelaere Anne-Sophie De , Shadid Samyah , Defreyne Justine , T'Sjoen Guy

Background: Gender-affirming hormone therapy in transgender persons induces secondary characteristics of the experienced gender. However, androgens and estrogens are also thought to be involved in insulin sensitivity and research suggests a dose-dependent risk for developing insulin resistance when administrated in supraphysiological doses.Aims: To assess the influence of gender-affirming hormone therapy on glucose metabolism in transg...

ea0056p936 | Female Reproduction | ECE2018

Child wish and fertility preservation in assigned female at birth transgender persons living in Belgium

Defreyne Justine , Van Schuylenbergh Judith , Wyverkens Elia , Motmans Joz , Tilleman Kelly , T'Sjoen Guy

Objectives: Gender affirming hormonal and/or surgical care is associated with reduced fertility. Over the last years, the options for transgender persons to fulfill their child wish have increased. Previous research (mainly focused on transgender persons visiting health care professionals) on fertility in transgender persons assigned female at birth (AFAB) shows low fertility preservation utilization. Ideas and concerns of AFAB transgender persons regarding fertility preservat...

ea0056p971 | Male Reproduction | ECE2018

Child wish and fertility preservation in assigned male at birth transgender persons living in Belgium

Defreyne Justine , Schuylenbergh Judith Van , Wyverkens Elia , Motmans Joz , T'Sjoen Guy

Objectives: Transgender persons undergoing gender affirming hormonal and/or surgical care, are at risk of reduced fertility. Although theoretically, the options for assigned male at birth (AMAB) transgender people to fulfill their child wish are extensive, research in transgender women shows low fertility preservation utilization. Ideas and concerns of AMAB transgender persons regarding fertility preservation and child wish have never been reported in a large, non-clinical sam...

ea0063gp109 | Calcium and Bone 2 | ECE2019

Sex steroids as determinants of Wnt-Signalling markers in men

Banica Thiberiu , Verroken Charlotte , Zmierczak Hans-Georg , Goemaere Stefan , Defreyne Justine , T'Sjoen Guy , Kaufman Jean-Marc , Lapauw Bruno

Background: Canonical Wnt-signalling is important for bone by regulating osteoblastogenesis and osteoblast function. Bone metabolism is also partly determined by sex steroid exposure and sex differences in serum sclerostin levels have been reported. However, it is unclear whether serum sclerostin and other circulating Wnt-signalling components are sex steroid dependent within healthy men.Objective: To determine whether serum sclerostin, osteoprotegerin (...

ea0056p667 | Neuroendocrinology | ECE2018

Does gender affirming hormone therapy affect anger proneness in transgender persons?

Defreyne Justine , Elaut Els , Kreukels Baudewijntje , Heylens Gunter , Schreiner Thomas , Fisher Alessandra Daphne , Heijer Martin Den , T'Sjoen Guy

Introduction: Anger is an emotional state of feelings varying from mild irritation to intense rage, whereas aggression implies externalizing angry emotions through destructive/ punitive behavior towards other persons/objects. Although research on the relationship between testosterone and aggression is inconclusive, the WPATH SOC 7 guidelines have warned for an increase in aggression in transgender men (TM) taking testosterone treatment.Aims:<p class=...

ea0073aep586 | Reproductive and Developmental Endocrinology | ECE2021

Changes in androgen profile in transgender women with or without gonadectomy

Collet Sarah , Defreyne Justine , Kiyar Meltem , De Meijer Delphine , Nobels Sarah , den Heijer Martin , Guy T’Sjoen

ObjectivesThe European Network for Investigation of Gender Incongruence (ENIGI) is a multicenter prospective cohort study. All participants receive a standardized gender affirming treatment (GAHT) protocol including regular follow-up. The current study compared changes in androgens upon starting GAHT and during follow-up in transgender women (TW) with or without gonadectomy by investigating serum total testosterone (TT), calculated free testosterone (cFT...